JAZZ PHARMACEUTICAL (J7Z.SG)
JAZZ PHARMACEUTICAL (J7Z.SG) operates in Diversified Metals & Mining.
Market Cap & Net Worth: JAZZ PHARMACEUTICAL (J7Z.SG) (J7Z)
JAZZ PHARMACEUTICAL (J7Z.SG) (STU:J7Z) has a market capitalization of $1.51 Million (€1.47 Million) as of March 18, 2026. Listed on the STU stock exchange, this Germany-based company holds position #35041 globally and #4096 in its home market, demonstrating a -3.49% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying JAZZ PHARMACEUTICAL (J7Z.SG)'s stock price €156.25 by its total outstanding shares 9393 (9.39K).
JAZZ PHARMACEUTICAL (J7Z.SG) Market Cap History: 2015 to 2026
JAZZ PHARMACEUTICAL (J7Z.SG)'s market capitalization history from 2015 to 2026. Data shows growth from $1.24 Million to $1.51 Million (2.66% CAGR).
JAZZ PHARMACEUTICAL (J7Z.SG) Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how JAZZ PHARMACEUTICAL (J7Z.SG)'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
JAZZ PHARMACEUTICAL (J7Z.SG)'s market cap is 0.00 times its annual revenue
0.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.00x
JAZZ PHARMACEUTICAL (J7Z.SG)'s market cap is 0.00 times its annual earnings
0.00x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $977.36K | $1.49 Billion | $396.83 Million | 0.00x | 0.00x |
| 2017 | $1.08 Million | $1.62 Billion | $487.85 Million | 0.00x | 0.00x |
| 2018 | $1.00 Million | $1.89 Billion | $447.10 Million | 0.00x | 0.00x |
| 2019 | $1.28 Million | $2.16 Billion | $523.37 Million | 0.00x | 0.00x |
| 2020 | $1.23 Million | $2.36 Billion | $238.62 Million | 0.00x | 0.01x |
| 2021 | $1.11 Million | $3.09 Billion | -$329.67 Million | 0.00x | N/A |
| 2022 | $1.41 Million | $3.66 Billion | -$224.06 Million | 0.00x | N/A |
| 2023 | $1.06 Million | $3.83 Billion | $414.83 Million | 0.00x | 0.00x |
Competitor Companies of J7Z by Market Capitalization
Companies near JAZZ PHARMACEUTICAL (J7Z.SG) in the global market cap rankings as of March 18, 2026.
Key companies related to JAZZ PHARMACEUTICAL (J7Z.SG) by market ranking:
- BERKSHIRE HATH-A (BE:BRH): Ranked #2328 globally with a market cap of $6.43 Billion USD ( €6.27 Billion EUR).
- BERKSHIRE HATH-A - Dusseldorf Stock Exchang (DU:BRH): Ranked #2395 globally with a market cap of $6.17 Billion USD ( €6.02 Billion EUR).
- Itissalat Al-Maghrib (IAM) S.A (PINK:MAOTF): Ranked #3760 globally with a market cap of $3.25 Billion USD.
- NET ONE SYSTEMS (MU:NOX): Ranked #4660 globally with a market cap of $2.24 Billion USD ( €2.18 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #2328 | BERKSHIRE HATH-A | BE:BRH | $6.43 Billion | €634500.00 |
| #2395 | BERKSHIRE HATH-A - Dusseldorf Stock Exchang | DU:BRH | $6.17 Billion | €638000.00 |
| #3760 | Itissalat Al-Maghrib (IAM) S.A | PINK:MAOTF | $3.25 Billion | $14.80 |
| #4660 | NET ONE SYSTEMS | MU:NOX | $2.24 Billion | €1000000.00 |
JAZZ PHARMACEUTICAL (J7Z.SG) Historical Marketcap From 2015 to 2026
Between 2015 and today, JAZZ PHARMACEUTICAL (J7Z.SG)'s market cap moved from $1.24 Million to $ 1.51 Million, with a yearly change of 2.66%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €1.51 Million | +9.34% |
| 2025 | €1.38 Million | +21.31% |
| 2024 | €1.14 Million | +6.99% |
| 2023 | €1.06 Million | -24.77% |
| 2022 | €1.41 Million | +27.66% |
| 2021 | €1.11 Million | -10.43% |
| 2020 | €1.23 Million | -3.76% |
| 2019 | €1.28 Million | +27.88% |
| 2018 | €1.00 Million | -7.52% |
| 2017 | €1.08 Million | +10.93% |
| 2016 | €977.36K | -21.25% |
| 2015 | €1.24 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of JAZZ PHARMACEUTICAL (J7Z.SG) was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.51 Million USD |
| MoneyControl | $1.51 Million USD |
| MarketWatch | $1.51 Million USD |
| marketcap.company | $1.51 Million USD |
| Reuters | $1.51 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.